174 related articles for article (PubMed ID: 10387894)
21. Endogenous sex hormones, breast cancer risk, and tamoxifen response: an ancillary study in the NSABP Breast Cancer Prevention Trial (P-1).
Beattie MS; Costantino JP; Cummings SR; Wickerham DL; Vogel VG; Dowsett M; Folkerd EJ; Willett WC; Wolmark N; Hankinson SE
J Natl Cancer Inst; 2006 Jan; 98(2):110-5. PubMed ID: 16418513
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention: drug pricing and mortality: the case of tamoxifen.
Melnikow J; Kuenneth C; Helms LJ; Barnato A; Kuppermann M; Birch S; Nuovo J
Cancer; 2006 Sep; 107(5):950-8. PubMed ID: 16865680
[TBL] [Abstract][Full Text] [Related]
23. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
24. The Breast Cancer Continuum: insights from the tamoxifen trials impact future drug development strategies.
Lewis JP
Ann N Y Acad Sci; 2001 Dec; 949():327-32. PubMed ID: 11795371
[TBL] [Abstract][Full Text] [Related]
25. Final results from the NSABP Breast Cancer Prevention Trial.
Oncology (Williston Park); 2005 Dec; 19(14):1800. PubMed ID: 16506633
[No Abstract] [Full Text] [Related]
26. Follow-up of the breast cancer prevention trial and the future of breast cancer prevention efforts.
Vogel VG
Clin Cancer Res; 2001 Dec; 7(12 Suppl):4413s-4418s; discussion 4411s-4412s. PubMed ID: 11916233
[TBL] [Abstract][Full Text] [Related]
27. Tamoxifen: an enduring star.
Veronesi U; Maisonneuve P; Decensi A
J Natl Cancer Inst; 2007 Feb; 99(4):258-60. PubMed ID: 17312297
[No Abstract] [Full Text] [Related]
28. Should you be taking tamoxifen?
Johns Hopkins Med Lett Health After 50; 2001 Jun; 13(4):4-5. PubMed ID: 11439691
[No Abstract] [Full Text] [Related]
29. Myxoid leiomyosarcoma of the uterus in a patient receiving tamoxifen therapy: a case report.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2006 Apr; 25(2):173-5. PubMed ID: 16633068
[TBL] [Abstract][Full Text] [Related]
30. Detection of endometrial cancer in asymptomatic postmenopausal breast cancer patient treated with tamoxifen: a case report.
Sinawat S; Chiyabutra T; Kleabkaew P
J Med Assoc Thai; 2001 Jul; 84(7):1033-6. PubMed ID: 11759963
[TBL] [Abstract][Full Text] [Related]
31. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
32. [Breast cancer chemoprevention. Rational, trials results and future].
Cutuli B; Lesur A; Namer M; Kerbrat P
Bull Cancer; 2009 May; 96(5):519-30. PubMed ID: 19467983
[TBL] [Abstract][Full Text] [Related]
33. [Chemoprevention of breast cancer: a hope justified?].
Buser K; Delaloye JF
Rev Med Suisse Romande; 2000 Jun; 120(6):511-3. PubMed ID: 11014095
[TBL] [Abstract][Full Text] [Related]
34. Controversies in the management of patients with breast cancer: adjuvant endocrine therapy in premenopausal women.
Parton M; Smith IE
J Clin Oncol; 2008 Feb; 26(5):745-52. PubMed ID: 18258982
[No Abstract] [Full Text] [Related]
35. Tamoxifen and breast cancer risk in women harboring a BRCA1 germline mutation: computed efficacy, effectiveness and impact.
Eisinger F; Charafe-Jauffret E; Jacquemier J; Birnbaum D; Julian-Reynier C; Sobol H
Int J Oncol; 2001 Jan; 18(1):5-10. PubMed ID: 11115532
[TBL] [Abstract][Full Text] [Related]
36. Chemoprevention of breast cancer for women at high risk.
Chan K; Morris GJ
Semin Oncol; 2006 Dec; 33(6):642-6. PubMed ID: 17145342
[TBL] [Abstract][Full Text] [Related]
37. How do we interpret the results of the Breast Cancer Prevention trial?
Margolese RG
CMAJ; 1998 Jun; 158(12):1613-4. PubMed ID: 9645175
[No Abstract] [Full Text] [Related]
38. Chemoprevention trends in breast cancer.
Lazzaro M; Mizell V; Thompson M; Weber D
Adv Nurse Pract; 1998 Nov; 6(11):26-8, 33-4, 74. PubMed ID: 9919058
[No Abstract] [Full Text] [Related]
39. Chemoprevention of breast cancer: a promising idea with an uncertain future.
Kinsinger LS; Harris R
Lancet; 2002 Sep; 360(9336):813-4. PubMed ID: 12243912
[No Abstract] [Full Text] [Related]
40. Tamoxifen for the prevention of breast cancer. Important questions remain unanswered, and existing trials should continue.
Bruzzi P
BMJ; 1998 Apr; 316(7139):1181-2. PubMed ID: 9552991
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
